MEDICATRONICS BELGIUM: what changed
What changed
MEDICATRONICS BELGIUM
NACE 46.460, Wholesale of pharmaceutical and medical goods
filed annual accounts (NBB)
Net result for the year
€37,237
2024 · €22,877+€14,360
Equity
€210,593
2024 · €173,357+€37,237
Cash
€8,273
2024 · €22,931-€14,658
Balance sheet total
€236,934
2024 · €198,023+€38,911
Largest movements
Assets
- Receivables within one year +€83,924
up €83,924 (+64.0%), from €131,198 to €215,122
of which Trade receivables: +€124,983
- Stocks and contracts -€31,250
down €31,250 (-88.4%), from €35,340 to €4,090
- Cash -€14,658
down €14,658 (-63.9%), from €22,931 to €8,273
mainly Receivables within one year (-€83,924) and Investment in fixed assets (net) (-€3,267)
Equity and liabilities
- Profit (loss) carried forward +€37,237
up €37,237 (+24.4%), from €152,897 to €190,133
Income statement
- Gross operating margin +€16,097
up €16,097 (+36.9%), from €43,658 to €59,755
- Taxes +€3,621
up €3,621 (+34.6%), from €10,461 to €14,081
- Staff costs -€1,242
down €1,242 (-98.5%), from €1,261 to €19
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€22,877
Gross operating margin
+€16,097
Staff costs
+€1,242
Depreciation
-€37
Other operating charges
+€303
Financial income
-€28
Financial charges
+€404
Taxes
-€3,621
Result 2025
€37,237
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
-€11,391
Investment
-€3,267
Financing
€0
Cash 2024
€22,931
From operations (derived)
-€11,391
Net result for the year
+€37,237
Depreciation
+€3,058
Stocks and contracts
+€31,250
Receivables within one year
-€83,924
Deferred charges and accrued income
-€686
Trade debts
+€1,587
Tax, wage and social debts
+€87
Investment (derived)
-€3,267
Investment in fixed assets (net)
-€3,267
Cash 2025
€8,273
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €198,023 | €236,934 | +€38,911 | +19.6% |
| Fixed assets | 21/28 | €8,554 | €8,763 | +€209 | +2.4% |
| Tangible fixed assets | 22/27 | €6,254 | €4,468 | -€1,786 | -28.6% |
| Plant, machinery and equipment | 23 | €4,678 | €3,033 | -€1,645 | -35.2% |
| Furniture and vehicles | 24 | €1,576 | €1,435 | -€141 | -9.0% |
| Financial fixed assets | 28 | €2,300 | €4,295 | +€1,995 | +86.7% |
| Current assets | 29/58 | €189,469 | €228,171 | +€38,702 | +20.4% |
| Stocks and contracts in progress | 3 | €35,340 | €4,090 | -€31,250 | -88.4% |
| Stocks | 30/36 | €35,340 | €4,090 | -€31,250 | -88.4% |
| Amounts receivable within one year | 40/41 | €131,198 | €215,122 | +€83,924 | +64.0% |
| Trade receivables | 40 | €53,832 | €178,814 | +€124,983 | +232% |
| Other amounts receivable | 41 | €77,366 | €36,308 | -€41,059 | -53.1% |
| Cash at bank and in hand | 54/58 | €22,931 | €8,273 | -€14,658 | -63.9% |
| Deferred charges and accrued income | 490/1 | - | €686 | +€686 | |
| Total equity and liabilities | 10/49 | €198,023 | €236,934 | +€38,911 | +19.6% |
| Equity | 10/15 | €173,357 | €210,593 | +€37,237 | +21.5% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €152,897 | €190,133 | +€37,237 | +24.4% |
| Amounts payable | 17/49 | €24,667 | €26,340 | +€1,674 | +6.8% |
| Amounts payable within one year | 42/48 | €24,667 | €26,340 | +€1,674 | +6.8% |
| Trade debts | 44 | - | €1,587 | +€1,587 | |
| Suppliers | 440/4 | - | €1,587 | +€1,587 | |
| Taxes, remuneration and social security | 45 | €24,667 | €24,754 | +€87 | +0.4% |
| Taxes | 450/3 | €24,264 | €24,351 | +€87 | +0.4% |
| Remuneration and social security | 454/9 | €403 | €403 | = | 0.0% |
| Remuneration, social security and pensions | 62 | €1,261 | €19 | -€1,242 | -98.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,021 | €3,058 | +€37 | +1.2% |
| Other operating charges | 640/8 | €1,964 | €1,661 | -€303 | -15.4% |
| Gross operating margin | 9900 | €43,658 | €59,755 | +€16,097 | +36.9% |
| Operating profit (loss) | 9901 | €37,413 | €55,017 | +€17,604 | +47.1% |
| Financial income | 75/76B | €107 | €79 | -€28 | -26.6% |
| Recurring financial income | 75 | €107 | €79 | -€28 | -26.6% |
| Financial charges | 65/66B | €4,182 | €3,777 | -€404 | -9.7% |
| Recurring financial charges | 65 | €4,182 | €3,777 | -€404 | -9.7% |
| Profit (loss) for the period before taxes | 9903 | €33,338 | €51,318 | +€17,980 | +53.9% |
| Income taxes | 67/77 | €10,461 | €14,081 | +€3,621 | +34.6% |
| Profit (loss) for the period | 9904 | €22,877 | €37,237 | +€14,360 | +62.8% |
| Profit (loss) for the period to be appropriated | 9905 | €22,877 | €37,237 | +€14,360 | +62.8% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.